Blonder Tongue Laboratories Announces Next Generation DRAKE PEG Encoder Line
Blonder Tongue Laboratories, Inc. (NYSE:BDR), a leading US-based designer and manufacturer of telecommunications, broadband and fiber optic transmission technologies, today announced the introduction of their next
59 Biggest Movers From Yesterday
Gainers
SeaChange International, Inc. (NASDAQ: SEAC) jumped 128.8% to $1.72 following Bloomberg report suggesting that social video app Triller is in merger talks with Seachange.
Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.67% to 35,728.62 while the NASDAQ fell 0.92% to 15,487.41. The S&P also fell, dropping 0.58% to 4,684.47.
Mid-Day Market Update: Nasdaq Drops Over 100 Points; Foghorn Therapeutics Shares Surge
Midway through trading Monday, the Dow traded down 0.81% to 35,679.10 while the NASDAQ fell 0.78% to 15,509.01. The S&P also fell, dropping 0.67% to 4,680.56.
40 Stocks Moving In Monday’s Mid-Day Session
Gainers
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.
Why Blonder Tongue Labs Shares Are Falling
Blonder Tongue Labs, Inc. (NASDAQ: BDR) shares are trading lower after the company announced it received notice today from NYSE American stating that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock from the exchange.
22 Stocks Moving in Monday’s Pre-Market Session
Gainers
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on Friday.
NYSE American To Commence Delisting Proceedings Against Blonder Tongue Laboratories
NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Blonder Tongue
Blonder Tongue Laboratories Warns On Supply Chain Disruptions After Q3 Performance
Blonder Tongue Laboratories Inc (NYSE: BDR)